Tinidazole: a nitroimidazole antiprotozoal agent.

[1]  R. Tuimala,et al.  Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration , 1984, Infection.

[2]  C. Nord,et al.  Tinidazole — microbiology, pharmacology and efficacy in anaerobic infections , 2005, Infection.

[3]  P. Nyirjesy,et al.  Treatment of Recurrent Bacterial Vaginosis With Tinidazole , 2004, Obstetrics and gynecology.

[4]  G. Manes,et al.  Tinidazole: from protozoa to Helicobacter pylori – the past, present and future of a nitroimidazole with peculiarities , 2004, Expert review of anti-infective therapy.

[5]  Hager Wd.  Treatment of Metronidazole-Resistant Trichomonas vaginalis With Tinidazole: Case Reports of Three Patients , 2004 .

[6]  M. Granström,et al.  The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication , 2004, Alimentary pharmacology & therapeutics.

[7]  V. Ahuja,et al.  Use of imidazole‐based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity , 2004, Journal of gastroenterology and hepatology.

[8]  V. Ahuja,et al.  Rank Order of Success Favors Longer Duration of Imidazole‐Based Therapy for Helicobacter pylori in Duodenal Ulcer Disease: A Randomized Pilot Study , 2004, Helicobacter.

[9]  Farahnaz Nariman,et al.  Susceptibilities to Different Antibiotics of Helicobacter pylori Strains Isolated from Patients at the Pediatric Medical Center of Tehran, Iran , 2004, Journal of Clinical Microbiology.

[10]  A. Gasbarrini,et al.  Six-Day or Seven-Day Regimens with Ranitidine Bismuth Citrate plus High-Dose Clarithromycin and Tinidazole Are Both Effective Against Helicobacter pylori Infection , 1999, Digestive Diseases and Sciences.

[11]  A. Czeizel,et al.  Oral tinidazole treatment during pregnancy and teratogenesis , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[12]  S. Batra,et al.  Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. , 2003, Indian journal of medical sciences.

[13]  T. Tasca,et al.  Effects of metronidazole and tinidazole on NTPDase1 and ecto-5'-nucleotidase from intact cells of Trichomonas vaginalis. , 2003, FEMS microbiology letters.

[14]  A. Gasbarrini,et al.  Levofloxacin‐based triple therapy vs. quadruple therapy in second‐line Helicobacter pylori treatment: a randomized trial , 2003, Alimentary pharmacology & therapeutics.

[15]  Anders Björkman,et al.  Identification of human cytochrome P450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data , 2003, European Journal of Clinical Pharmacology.

[16]  S. Joshi,et al.  Efficacy and tolerability of a combination of ofloxacin and tinidazole in the management of infectious diabetic foot ulcer. , 2003, Journal of the Indian Medical Association.

[17]  W. Secor,et al.  In Vitro Metronidazole and Tinidazole Activities against Metronidazole- Resistant Strains of Trichomonas vaginalis , 2003, Antimicrobial Agents and Chemotherapy.

[18]  C. Hassan,et al.  High eradication rates of Helicobacter pylori with a new sequential treatment , 2003, Alimentary pharmacology & therapeutics.

[19]  H. Hänel,et al.  Nitroheterocyclic drugs with broad spectrum activity , 2003, Parasitology Research.

[20]  P. Malfertheiner,et al.  Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report , 2002, Alimentary pharmacology & therapeutics.

[21]  H. C. Jung,et al.  Efficacy of low‐dose clarithromycin triple therapy and tinidazole‐containing triple therapy for Helicobacter pylori eradication , 2002, Alimentary pharmacology & therapeutics.

[22]  P. Malfertheiner.  European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection. The Maasticht 2-2000 Consensus Report , 2002 .

[23]  P. Nyirjesy,et al.  Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  C. Hassan,et al.  A triple therapy regimen after failed Helicobacter pylori treatments , 2001, Alimentary pharmacology & therapeutics.

[25]  T. Gardner,et al.  Treatment of Giardiasis , 2001, Clinical Microbiology Reviews.

[26]  Atha,et al.  The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme , 2000, Alimentary pharmacology & therapeutics.

[27]  X. Calvet,et al.  Four‐Day, Twice Daily, Quadruple Therapy with Amoxicillin, Clarithromycin, Tinidazole and Omeprazole to Cure Helicobacter pylori Infection: A Pilot Study , 2000, Helicobacter.

[28]  E. S. Torre,et al.  Efficacy of a multistep strategy for Helicobacter pylori eradication , 2000, Alimentary pharmacology & therapeutics.

[29]  Gasbarrini,et al.  Five‐day regimens containing ranitidine bismuth citrate plus high‐dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection , 2000, Alimentary pharmacology & therapeutics.

[30]  P. Nyirjesy,et al.  Metronidazole-resistant vaginal trichomoniasis--an emerging problem. , 1999, The New England journal of medicine.

[31]  H. Straatman,et al.  Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysis , 1999, Alimentary pharmacology & therapeutics.

[32]  Lawes,et al.  Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer‐associated and non‐ulcer dyspepsia , 1999, Alimentary pharmacology & therapeutics.

[33]  R. Hunt,et al.  Guidelines for the management of Helicobacter pylori infection , 1998, American Journal of Gastroenterology.

[34]  Reina,et al.  Efficacy and safety of three 7‐day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate , 1998, Alimentary pharmacology & therapeutics.

[35]  A. V. van Zwet,et al.  One‐week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance , 1997, Alimentary pharmacology & therapeutics.

[36]  W. Secor,et al.  In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis , 1996, Antimicrobial agents and chemotherapy.

[37]  A. Kharsany,et al.  Antimicrobial susceptibilities of Gardnerella vaginalis , 1993, Antimicrobial Agents and Chemotherapy.

[38]  K. Dhar,et al.  Tinidazole prophylaxis in elective abdominal hysterectomy , 1993, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[39]  K. Dhar,et al.  Single dose tinidazole prophylaxis in vaginal hysterectomy , 1993, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[40]  T. Jetsawangsri,et al.  Split‐dose Metronidazole or Single‐dose Tinidazole for the Treatment of Vaginal Trichomoniasis , 1992, Sexually transmitted diseases.

[41]  A. Matlow,et al.  Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents , 1992, Antimicrobial Agents and Chemotherapy.

[42]  J. Lossick,et al.  Trichomoniasis: trends in diagnosis and management. , 1991, American journal of obstetrics and gynecology.

[43]  A. Gupta,et al.  Clinical profile of giardiasis and comparison of its therapeutic response to metronidazole and tinidazole. , 1991, The Journal of the Association of Physicians of India.

[44]  S. Sears,et al.  In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents , 1988, Antimicrobial Agents and Chemotherapy.

[45]  P. Sarma.  Tinidazole: a new drug in the treatment of vivax malaria , 1988 .

[46]  K. Mohanty,et al.  Comparison of 2 g single dose of metronidazole, nimorazole and tinidazole in the treatment of vaginitis associated with Gardnerella vaginalis. , 1987, The Journal of antimicrobial chemotherapy.

[47]  L. Jokipii,et al.  Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius , 1987, Antimicrobial Agents and Chemotherapy.

[48]  P. Männistö,et al.  Effect of enzyme induction and inhibition on the fate of metronidazole and tinidazole in the rat. , 1987, Pharmacology & toxicology.

[49]  V. Mahakittikun,et al.  In vitro studies on the sensitivity of local Entamoeba histolytica to anti-amoebic drugs. , 1986, The Southeast Asian journal of tropical medicine and public health.

[50]  J. K. Faulkner,et al.  Pharmacokinetics and metabolism of 14C-tinidazole in humans. , 1986, The Journal of antimicrobial chemotherapy.

[51]  A. Simjee,et al.  A comparative trial of metronidazole v. tinidazole in the treatment of amoebic liver abscess. , 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[52]  P. Mannisto,et al.  Concentrations of metronidazole and tinidazole in male genital tissues , 1985, Antimicrobial Agents and Chemotherapy.

[53]  J. Butzler,et al.  In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents , 1985, Antimicrobial Agents and Chemotherapy.

[54]  P. Speelman,et al.  Single-dose tinidazole for the treatment of giardiasis , 1985, Antimicrobial Agents and Chemotherapy.

[55]  T. Bergan.  Antibacterial activity and pharmacokinetics of nitroimidazoles. A review. , 1985, Scandinavian journal of infectious diseases. Supplementum.

[56]  Ross R. Bailey,et al.  Tinidazole Pharmacokinetics in Severe Renal Failure , 1984, Clinical pharmacokinetics.

[57]  B. Flouvat,et al.  Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis. , 1983, British journal of clinical pharmacology.

[58]  R. Mäntylä,et al.  Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route , 1983, Antimicrobial Agents and Chemotherapy.

[59]  P. Chaikin,et al.  Pharmacokinetics of Tinidazole in Male and Female Subjects , 1982, Journal of clinical pharmacology.

[60]  R. Thin,et al.  Single Dose Treatment of Trichomoniasis , 1982, The Journal of international medical research.

[61]  L. Clarke,et al.  Pharmacokinetics of Nitroimidazoles , 1982 .

[62]  C. Nord,et al.  Concentrations of tinidazole and metronidazole in serum, saliva and alveolar bone. , 1982, The Journal of antimicrobial chemotherapy.

[63]  A. Monro,et al.  The pharmacokinetics, metabolism and tissue distribution of tinidazole. , 1982, The Journal of antimicrobial chemotherapy.

[64]  P. Cocks.  Prophylactic tinidazole for hysterectomy--experience of 870 cases during 1980 and 1981. , 1982, The Journal of antimicrobial chemotherapy.

[65]  Andersson Ke.  Pharmacokinetics of nitroimidazoles. Spectrum of adverse reactions. , 1981 .

[66]  H. Kyrönseppä,et al.  Treatment of giardiasis: relative efficacy of metronidazole as compared with tinidazole. , 1981, Scandinavian journal of infectious diseases.

[67]  L. Jokipii,et al.  Single-dose metronidazole and tinidazole as therapy for giardiasis: success rates, side effects, and drug absorption and elimination. , 1979, The Journal of infectious diseases.

[68]  K. Krishnamurthy,et al.  Single dose therapy of giardiasis: a comparative study of tinidazole and metronidazole in pediatric patients. , 1978, Indian pediatrics.

[69]  S. Majumdar,et al.  Comparative evaluation of tinidazole and metronidazole in the treatment of amoebic liver abscess. , 1977, Journal of the Indian Medical Association.

[70]  L. Jokipii,et al.  Penetration of the blood brain barrier by metronidazole and tinidazole. , 1977, The Journal of antimicrobial chemotherapy.

[71]  R. Gupta,et al.  A Comparison of a Short Course of Single Daily Dosage Therapy of Tinidazole with Metronidazole in Intestinal Amoebiasis , 1973, The Journal of international medical research.

[72]  G. Singh,et al.  Short course of single daily dosage treatment with tinidazole and metronidazole in intestinal amoebiasis: a comparative study. , 1977, Current medical research and opinion.

[73]  C. Devi,et al.  Tinidazole and metronidazole in the treatment of intestinal amoebiasis. , 1977, Current medical research and opinion.

[74]  K. Andersson,et al.  Concentrations of tinidazole in body fluids and tissues in gynaecological patients. , 1977, Chemotherapy.

[75]  S. Olupitan,et al.  Tinidazole in the treatment of amoebic liver abscess. , 1976, Current therapeutic research, clinical and experimental.

[76]  N. Islam,et al.  Tinidazole in the treatment of intestinal amoebiasis. , 1975, Current therapeutic research, clinical and experimental.

[77]  A. Monro,et al.  Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses. , 1975, The British journal of venereal diseases.

[78]  J. Mati,et al.  The treatment of trichomonal vaginitis using a single dose of tinidazole by mouth. , 1974, East African medical journal.

[79]  P. Rees,et al.  Single-dose treatment of vaginal trichomoniasis with tinidazole. , 1974, East African medical journal.

[80]  A. W. Diddle.  Trichomonas vaginalis: resistance to metronidazole. , 1967, American journal of obstetrics and gynecology.